XRAY DENTSPLY SIRONA Inc.

Patterson Dental and Dentsply Sirona Renew U.S. Dental Technology Distribution Partnership

Patterson Dental and Dentsply Sirona Renew U.S. Dental Technology Distribution Partnership

The renewed agreement marks a strategic step toward accelerating growth and expanding access to integrated, high-quality dental technology solutions that help dental professionals elevate patient care

CHARLOTTE, N.C., Jan. 14, 2026 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (Nasdaq: XRAY), the world’s largest diversified manufacturer of professional dental products and technologies, and Patterson Dental Holdings (“Patterson Dental”), a leading supplier of products and services to the dental and animal health end markets, today announced the renewal of their U.S. dental technology distribution agreement. This renewed partnership reflects both companies’ commitment to supporting dental professionals with advanced technologies and expert service while setting a clear focus on driving growth and innovation in the years ahead.

A Partnership Focused on the Future

Dentsply Sirona and Patterson Dental have worked together for decades to bring digital solutions to dental practices across the country. This renewed agreement underscores a shared determination to accelerate adoption of integrated technologies that help practices operate more efficiently and deliver better patient outcomes.

As dentistry enters a new era of , the companies aim to strengthen access to a comprehensive ecosystem that links devices, software, and services—from scanning to design and manufacturing—creating opportunities for practices to enhance productivity and patient care.

Impact for Dental Professionals

Under the renewed agreement, Patterson Dental customers in the U.S. will continue to have access to Dentsply Sirona’s full portfolio of dental technology solutions, including the CEREC system, Primescan intraoral scanners, and Axeos and Orthophos imaging systems—all backed by expert service and support.

Both companies see this as a strategic opportunity to reignite growth and help dental professionals succeed in a rapidly changing environment.

“Renewing this agreement is about looking ahead,” said Aldo Denti, Executive Vice President, Chief Commercial Officer at Dentsply Sirona. “We value our relationship with Patterson Dental and are committed to working together to expand access to solutions that empower dental professionals to succeed.”

“We’re excited to build on our long history of innovation with Dentsply Sirona,” said Patrik Eriksson, President of Patterson Dental. “Together, we’ll broaden access to solutions that accelerate practice growth and enable clinicians to deliver exceptional care.”

About Dentsply Sirona

Dentsply Sirona is the world’s largest diversified manufacturer of professional dental products and technologies, with over a century of innovation and service to the dental industry and patients worldwide. Dentsply Sirona develops, manufactures, and markets a comprehensive solutions offering including dental and oral health products as well as other consumable medical devices under a strong portfolio of world-class brands. Dentsply Sirona’s innovative products provide high-quality, effective and connected solutions to advance patient care and deliver better and safer dental care. Dentsply Sirona is headquartered in Charlotte, North Carolina. The Company’s shares are listed in the United States on Nasdaq under the symbol XRAY. Visit for more information about Dentsply Sirona and its products.

About Patterson Companies

Patterson Companies, Inc. connects dental and animal health customers in North America and the U.K. to the latest products, technologies, services, and innovative business solutions that enable operational and professional success. Our comprehensive portfolio, distribution network and supply chain are equaled only by our dedicated, knowledgeable people who deliver unrivaled expertise and unmatched customer service and support.

Learn more: pattersoncompanies.com, pattersondental.com

Registered brands, trade names and logos are used. Even in particular cases, when they appear without a TM or ®, all corresponding legal rules and provisions apply. All rights are retained by Dentsply Sirona. Clinicians may have been compensated for use of their experiences and testimonials. Due to the different approval and registration times, not all technologies and products are immediately available in all countries. Please reach out to a local dealer or sales representative for more information.

Contact Information:

Dentsply Sirona Press Contact:

Marion Par-Weixlberger

Vice President, Public Relations & Corporate Communications

|

Patterson Companies Press Contact:

Patrick Strait, APR

Corporate Communications Manager

|

Dentsply Sirona Investors:

Wade Moody

Senior Manager, Investor Relations



EN
14/01/2026

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on DENTSPLY SIRONA Inc.

Dentsply Sirona Inc.: Update to credit analysis

Our credit view of this issuer reflects its moderate financial leverage and its strong market position in the dental device industry, against its high reliance on distributors.

Dentsply Sirona Inc: 2 directors

Two Directors at Dentsply Sirona Inc bought 20,000 shares at between 12.445USD and 12.480USD. The significance rating of the trade was 70/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors ove...

 PRESS RELEASE

First-ever Dental Dedicated MRI Validated in Clinical Trial and Cleare...

First-ever Dental Dedicated MRI Validated in Clinical Trial and Cleared by FDA for Advanced Soft-Tissue Diagnostics Dentsply Sirona and Siemens Healthineers are pleased to announce that the first-ever dental-dedicated MRI1 (ddMRI) system – MAGNETOM Free.Max Dental Edition – has received FDA clearance in the United States. This milestone follows the completion of a clinical trial2 validating the system’s significant potential across multiple dental specialties. The trial highlighted this first-of-its-kind technology’s applicability in endodontics, periodontics, TMJ, tooth extraction, and ort...

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Weekly Report: March 7, 2026

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

ResearchPool Subscriptions

Get the most out of your insights

Get in touch